ArticleCancers2020

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study.

Ulrich-Frank Pape et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.